FDA Approves Injectafer® Single Dose Option for Iron Deficiency Anemia
Injectafer® (ferric carboxymaltose injection) has received approval by the FDA for a single dose option for the treatment of adult
Read moreInjectafer® (ferric carboxymaltose injection) has received approval by the FDA for a single dose option for the treatment of adult
Read moreThe European Commission has approved Astellas’ XTANDI™ (enzalutamide) for men with metastatic Hormone-Sensitive Prostate Cancer (mHSPC). Japanese multinational pharmaceutical company
Read moreThe announced temporary waiver of COVID-19 vaccine patents by Joe Biden’s administration has hit vaccine maker shares and raised serious
Read moreCanada has become the first country in the world to authorize the use of the Pfizer-BioNTech COVID-19 vaccine in adolescents
Read moreThe COVID-19 treatment XAV-19, developed by French biotech company XENOTHERA, has started a European clinical trial in partnership with Contract
Read moreLow-income countries can benefit from the latest Moderna – Gavi agreement, which is set up to distribute up to 500
Read morePfizer announced on Wednesday, the acquisition of Amplyx Pharmaceuticals, Inc., a privately-owned company focused on the engineering of treatments for
Read moreEvotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) revealed that it has invested in OxVax, a new immuno-oncology organization
Read moreBristol-Myers Squibb is investing in a brand new cell therapy facility which will be located at the Leiden Bio Science
Read moreIrish pharmaceutical company Shorla Pharma Limited (‘Shorla’), has reported that it has successfully filed a priority review application for its
Read more